Tag: NAFLD

All

New Precision Medicine Platform Supports Disease Areas With Unmet Medical Needs

The new biorepository can be instrumental in genetic and biomarker identification for patient populations with rapid disease progression.

Siemens’ Enhanced Liver Fibrosis Test Gets FDA Breakthrough Device Designation
New Method Improves Diagnosis of Fatty Liver Disease
Researchers Develop Blood Test to Predict Liver Cancer Risk
New Blood Biomarker Identifies Status of Fatty Liver Disease
New Non-Invasive Methods for Better Diagnosing Liver Diseases
Fatty Liver Disease Testing & Awareness Campaign Launches this Summer
Roughly a Quarter of Adults Have a Liver Disorder Linked to High Heart Disease Risk
Blood Test Identifies Risk of Nonalcoholic Fatty Liver Disease
The Battle against “Silent” Liver Disease

All

Genfit, LabCorp to Commercialize a Novel Diagnostic for Liver Disease

LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4 technology to help identify patients with at-risk nonalcoholic steatohepatitis.

Giant Leap in Diagnosing Liver Disease
ProSciento and Nordic Bioscience Partner to Develop Translational Biomarkers for NASH
Siemens Healthineers Launches Testing Service for Chronic Liver Disease
Echosens FibroScan Selected for Pilot Study by NASH Network

Tag: NAFLD

All

New Precision Medicine Platform Supports Disease Areas With Unmet Medical Needs

Siemens’ Enhanced Liver Fibrosis Test Gets FDA Breakthrough Device Designation

New Method Improves Diagnosis of Fatty Liver Disease

Researchers Develop Blood Test to Predict Liver Cancer Risk

New Blood Biomarker Identifies Status of Fatty Liver Disease

New Non-Invasive Methods for Better Diagnosing Liver Diseases

Fatty Liver Disease Testing & Awareness Campaign Launches this Summer

Roughly a Quarter of Adults Have a Liver Disorder Linked to High Heart Disease Risk

Blood Test Identifies Risk of Nonalcoholic Fatty Liver Disease

The Battle against “Silent” Liver Disease

All

Genfit, LabCorp to Commercialize a Novel Diagnostic for Liver Disease

Giant Leap in Diagnosing Liver Disease

ProSciento and Nordic Bioscience Partner to Develop Translational Biomarkers for NASH

Siemens Healthineers Launches Testing Service for Chronic Liver Disease

Echosens FibroScan Selected for Pilot Study by NASH Network

All

Sorry, No Posts Found

Sorry, No Posts Found

Clinical Lab Products

Our Parent Company

Key Resources

Helpful Links